The neurotoxicity of hallucinogenic amphetamines in primary cultures of hippocampal neurons

NeuroToxicology

Volumn 34, Issue 1, 2013, Pages 254-263

  Capela, João Paulo ^a,b   da Costa Araújo, Silvana ^a   Costa, Vera Marisa ^a   Ruscher, Karsten ^c   Fernandes, Eduarda ^a   Bastos, Maria de Lourdes ^a   Dirnagl, Ulrich ^d   Meisel, Andreas ^d   Carvalho, Félix ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSIDADE FERNANDO PESSOA   (Portugal)

^c LUND UNIVERSITY   (Sweden)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

5 HT2A receptors; AIF; Amphetamines; Apoptosis; Caspases; DOI; Hallucinogens; Hippocampus; MDMA

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; APOPTOSIS INDUCING FACTOR; CASPASE 3; CASPASE 8; CYTOCHROME C; LACTATE DEHYDROGENASE; SEROTONIN 2A RECEPTOR; TETRAZOLIUM;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CELL FRACTIONATION; CELL MATURATION; CONCENTRATION (PARAMETERS); CYTOTOXICITY TEST; EMBRYO; ENZYME ACTIVATION; ENZYME ASSAY; ENZYME RELEASE; HIPPOCAMPUS; LONG TERM EXPOSURE; MITOCHONDRIAL MEMBRANE POTENTIAL; MULTICENTER STUDY; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; PRIMARY CELL CULTURE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

AMPHETAMINES; ANIMALS; APOPTOSIS INDUCING FACTOR; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CASPASE 3; CASPASE 8; CELL SURVIVAL; CELLS, CULTURED; CYTOCHROMES C; DOSE-RESPONSE RELATIONSHIP, DRUG; GESTATIONAL AGE; HALLUCINOGENS; HIPPOCAMPUS; L-LACTATE DEHYDROGENASE; MITOCHONDRIA; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEURONS; NEUROTOXICITY SYNDROMES; PRIMARY CELL CULTURE; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN 5-HT2 RECEPTOR ANTAGONISTS; TIME FACTORS;

RATTUS NORVEGICUS;

EID: 84872677219     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2012.09.005     Document Type: Article

References (48)

1. Adamaszek M., Khaw A.V., Buck U., Andresen B., Thomasius R. Evidence of neurotoxicity of ecstasy: sustained effects on electroencephalographic activity in polydrug users. PLoS One 2010, 5:e14097.
2. ádori C., Andó R.D., Kovács G.G., Bagdy G. Damage of serotonergic axons and immunolocalization of Hsp27, Hsp72, and Hsp90 molecular chaperones after a single dose of MDMA administration in Dark Agouti rat: temporal, spatial, and cellular patterns. J Comp Neurol. 2006, 497:251-269.
3. Ali S.F., Newport G.D., Scallet A.C., Binienda Z., Ferguson S.A., Bailey J.R., et al. Oral administration of 3,4-methylenedioxymethamphetamine (MDMA) produces selective serotonergic depletion in the nonhuman primate. Neurotoxicol Teratol 1993, 15:91-96.
4. Arias-Cavieres A., Rozas C., Reyes-Parada M., Barrera N., Pancetti F., Loyola S., et al. MDMA (" ecstasy") impairs learning in the Morris water maze and reduces hippocampal LTP in young rats. Neurosci Lett 2010, 469:375-379.
5. Battaglia G., Brooks B., Kulsakdinun C., Souza E.D. Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites. Eur J Pharmacol 1988, 149:159-163.
6. Brewer G.J. Serum-free B27/neurobasal medium supports differentiated growth of neurons from the striatum, substantia nigra, septum, cerebral cortex, cerebellum, and dentate gyrus. J Neurosci Res 1995, 42:674-768.
7. Capela J.P., Carmo H., Remião F., Bastos M., Meisel A., Carvalho F. Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. Mol. Neurobiol. 2009, 39:210-271.
8. Capela J.P., Fernandes E., Remiao F., Bastos M.L., Meisel A., Carvalho F. Ecstasy induces apoptosis via 5-HT2A-receptor stimulation in cortical neurons. Neurotoxicology 2007, 28:868-875.
9. Capela J.P., Meisel A., Abreu A.R., Branco P.S., Ferreira L.M., Lobo A.M., et al. Neurotoxicity of ecstasy metabolites in rat cortical neurons, and influence of hyperthermia. J Pharmacol Exp Ther 2006, 316:53-61.
10. Capela J.P., Ruscher K., Lautenschlager M., Freyer D., Dirnagl U., Gaio A.R., et al. Ecstasy-induced cell death in cortical neuronal cultures is serotonin 2A-receptor-dependent and potentiated under hyperthermia. Neuroscience 2006, 139:1069-1081.
11. Cho K.-O., Kim S.-K., Rhee G.S., Kwack S.J., Cho D.H., Sung K.W., et al. Chronic 3,4-methylenedioxymethamphetamine treatment suppresses cell proliferation in the adult mouse dentate gyrus. Eur J Pharmacol 2007, 566:120-123.
12. Chu T., Kumagai Y., DiStefano E.W., Cho A.K. Disposition of methylenodioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion. Biochem Pharmacol 1996, 51:789-796.
13. Cohen A.M., Skelton R.M., Schaefer T.L., Gudelsky G.A., Vorhees C., Williams M.T. Learning and memory after neonatal exposure to 3,4-methylenedioxymethamphetamine (ecstasy) in rats: interaction with exposure in adulthood. Synapse 2005, 57:148-159.
14. Commins D.L., Vosmer G., Virus R.M., Woolverton W.L., Schuster C.R., Seiden L.S. Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. J Pharmacol Exp Ther 1987, 241:338-345.
15. Cregan S.P., Dawson V.L., Slack R.S. Role of AIF in caspase-dependent and caspase-independent cell death. Oncogene 2004, 23:2785-2796.
16. Cunha-Oliveira T., Rego A.C., Cardoso S.M., Borges F., Swerdlow R.H., Macedo T., et al. Mitochondrial dysfunction and caspase activation in rat cortical neurons treated with cocaine or amphetamine. Brain Res 2006, 1089:44-54.
17. Daumann J., Fischermann T., Heekeren K., Henke K., Thron A., Gouzoulis-Mayfrank E. Memory-related hippocampal dysfunction in poly-drug ecstasy (3,4-methylenedioxymethamphetamine) users. Psychopharmacology 2005, 180:607-611.
18. Dawson V.L., Dawson T.M. Deadly conversations: nuclear-mitochondrial cross-talk. J Bioenerg Biomembr 2004, 36:287-294.
19. Gouzoulis-Mayfrank E., Thimm B., Rezk M., Hensen G., Daumann J. Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users. Prog Neuropsychopharmacol Biol Psychiatry 2003, 27:819-827.
20. Hatzidimitriou G., McCann U.D., Ricaurte G.A. Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery. J Neurosci 1999, 15:5096-5107.
21. Hernandez-Rabaza V., Dominguez-Escriba L., Barcia J.A., Rosel J.F., Romero F.J., Garcia-Verdugo J.M., et al. Binge administration of 3,4-methylenedioxymethamphetamine (" ecstasy") impairs the survival of neural precursors in adult rat dentate gyrus. Neuropharmacology 2006, 51:967-973.
22. Hori N., Kadota M., Watanabe M., Ito Y., Akaike N., Carpenter D. Neurotoxic effects of methamphetamine on rat hippocampus pyramidal neurons. Cell Mol Neurobiol 2010, 30:849-856.
23. Jimenez A., Jorda E.G., Verdaguer E., Pubill D., Sureda F.X., Canudas A.M., et al. Neurotoxicity of amphetamine derivatives is mediated by caspase pathway activation in rat cerebellar granule cells. Toxicol Appl Pharmacol 2004, 196:223-234.
24. Johnson E.A., O'Callaghan J.P., Miller D.B. Brain concentrations of d-MDMA are increased after stress. Psychopharmacology 2004, 173:278-286.
25. Kanthasamy A., Anantharam V., Ali S.F., Kanthasamy A.G. Methamphetamine induces autophagy and apoptosis in a mesencephalic dopaminergic neuronal culture model: role of cathepsin-d in methamphetamine-induced apoptotic cell death. Ann NY Acad Sci 2006, 1074:234-244.
26. Krantic S., Mechawar N., Reix S., Quirion R. Apoptosis-inducing factor: a matter of neuron life and death. Prog Neurobiol 2007, 81:179-196.
27. Krasnova I.N., Ladenheim B., Cadet J.L. Amphetamine induces apoptosis of medium spiny striatal projection neurons via the mitochondria-dependent pathway. FASEB J 2005, 19:851-853.
28. McCann U., Mertl M., Eligulashvili V., Ricaurte G. Cognitive performance in 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) users: a controlled study. Psychopharmacology 1999, 143:417-425.
29. McCann U.D., Szabo Z., Scheffel U., Dannals R.F., Ricaurte G.A. Positron emission tomographic evidence of toxic effect of MDMA (" Ecstasy") on brain serotonin neurones in human beings. Lancet 1998, 352:1433-1437.
30. Meyer J.S., Grande M., Johnson K., Ali S.F. Neurotoxic effects of MDMA (" ecstasy") administration to neonatal rats. Int J Dev Neurosci 2004, 22:261-271.
31. Nelson D.L., Lucaites V.L., Wainscott D.B., Glennon R.A. Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, 5-HT2B and 5-HT2C receptors. N-S Arch Pharmacol 1999, 359:1-6.
32. Nichols D.E. Hallucinogens. Pharmacol Ther 2004, 101:131-181.
33. Nulsen C., Fox A., Hammond G. Electrophysiological indices of altered working memory processes in long-term ecstasy users. Hum Psychopharmacol 2011, 26:488-497.
34. Rego A.C., Vesce S., Nicholls D.G. The mechanism of mitochondrial membrane potential retention following release of cytochrome c in apoptotic GT1-7 neural cells. Cell Death Differ 2001, 8:995-1003.
35. Reneman L., Booij J., de Bruin K., Reitsma J.B., de Wolff F.A., Gunning W.B., et al. Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Lancet 2001, 358:1864-1869.
36. Ricaurte G.A., Yuan J., McCann U.D. (±)3,4-Methylenedioxymethamphetamine (" Ecstasy")-induced serotonin neurotoxicity: studies in animals. Neuropsychobiology 2000, 42:5-10.
37. Rodgers J. Cognitive performance amongst recreational users of "ecstasy". Psychopharmacology 2000, 151:19-24.
38. Ruscher K., Freyer D., Karsch M., Isaev N., Megow D., Sawitzki B., et al. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J Neurosci 2002, 22:10291-10301.
39. Schmidt C.J., Levin J.A., Lovenberg W. In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain. Biochem Pharmacol 1987, 36:747-755.
40. Schmued L. Demonstration and localization of neuronal degeneration in the rat forebrain following a single exposure to MDMA. Brain Res 2003, 974:127-133.
41. Sprague J.E., Preston A.S., Leifheit M., Woodside B. Hippocampal serotonergic damage induced by MDMA (ecstasy): effects on spatial learning. Physiol Behav 2003, 79:281-287.
42. Stumm G., Schlegel J., Schafer T., Wurz C., Mennel H., Krieg J., et al. Amphetamines induce apoptosis and regulation of bcl-x splice variants in neocortical neurons. FASEB J 1999, 13:1065-1072.
43. Tamburini I., Blandini F., Gesi M., Frenzilli G., Nigro M., Giusiani M., et al. MDMA induces caspase-3 activation in the limbic system but not in striatum. Ann N Y Acad Sci 2006, 1074:377-381.
44. UNODC World drug report 2011 2011, United Nations Office on Drugs and Crime (UNODC), Vienna, Austria.
45. van Wel J.H.P., Kuypers K.P.C., Theunissen E.L., Bosker W.M., Bakker K., Ramaekers J.G. Blockade of 5-HT2 receptor selectively prevents MDMA-induced verbal memory impairment. Neuropsychopharmacology 2011, 36:1932-1939.
46. Warren M., Larner S., Kobeissy F., Brezing C., Jeung J., Hayes R., et al. Calpain and caspase proteolytic markers co-localize with rat cortical neurons after exposure to methamphetamine and MDMA. Acta Neuropathol 2007, 114:277-286.
47. Wertz I.E., Dixit V.M. Regulation of death receptor signaling by the ubiquitin system. Cell Death Differ 2010, 17:14-24.
48. Xu T., Pandey S.C. Cellular localization of serotonin2A (5HT2A) receptors in the rat brain. Brain Res Bull 2000, 51:499-505.